News – Page 54 – Endpoints News

Teva, Astellas plan to participate in IRA drug price negotiations

4 months ago

Purdue, Sacklers reach new $7.4B opioid settlement after SCOTUS rejection

4 months ago

Catalent to make CAR-T for Galapagos; Kindeva gets $129M for nerve agent antidote

4 months ago

What health tech wants from a Trump administration

4 months ago

AbbVie partners with Neomorph in latest molecular glue deal

4 months ago

FDA delays decision on Stealth’s Barth syndrome drug; TargetRx raises $50M

4 months ago

With $275M in fresh funding, Innovaccer's looking to make more health tech deals

4 months ago

BioMarin turns to ex-Roche dealmaker James Sabry to build ‘next version’ of 27-year-old company

4 months ago

Anthos' detailed mid-stage data back its anticoagulant, but can the drug succeed where Bayer's failed?

4 months ago

Teva’s MS drug and generics to add black box warning for anaphylaxis

4 months ago

AstraZeneca exec stresses Calquence's patent life ahead of next Medicare negotiations

4 months ago

Vanda loses constitutional fight over FDA's drug talks with competitors

4 months ago

J&J reinforces Caplyta blockbuster projections, won't shelve neuro prospects

4 months ago

Chinese startup begins first trial of in vivo CRISPR therapy for blood disease

4 months ago

Samsung Bio hits revenue high, secures largest contract to date

4 months ago

Exclusive: Health navigator Quantum Health cuts 4% of workforce

4 months ago

Updated: Biogen makes cuts across its research unit, shifting focus to ‘external opportunities’

4 months ago

RFK Jr. says he’ll divest interests in CRISPR Therapeutics if confirmed for HHS chief

4 months ago

Xilio reports handful of responses for combo in colorectal cancer

4 months ago

Shanghai Bao, Sichuan Biokin file IPOs in Hong Kong; Disc's $200M offering

4 months ago

Tris Pharma declares Phase 3 win for 'opioid-like' painkiller. Can it sell?

4 months ago

J&J’s Spravato hit $1B in revenue in 2024

4 months ago

Inhibrx’s early colorectal cancer data clouded by patient death

4 months ago

'No miracles': What Regeneron's George Yancopoulos really thinks of AI

4 months ago

First page Previous page 51 52 535455 56 57 Next page Last page